comparemela.com

Four-year follow-up data reinforces the consistent effectiveness and safety of treatment with edoxaban in patients with atrial fibrillation (AF)

Four-year follow-up data reinforces the consistent effectiveness and safety of treatment with edoxaban in patients with atrial fibrillation (AF)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Italy ,Van Mieghem ,Stefan Seyfried ,Wolfgang Schiessl ,Daiichi Sankyo Europe ,Daiichi Sankyo Europe Gmb ,Daiichi Sankyo ,Atrial Fibrillation Network ,European Society Of Cardiology ,Pisa University Hospital ,European Heart Rhythm Association Practical ,University Of Pisa ,European Society Of Cardiology Congress ,University Cardiology Division ,Sankyo Europe ,European Society ,Modified Frailty Index ,Professor Raffaele De Caterina ,Cardiology Congress ,Vice President ,Medical Affairs ,Specialty Medicines ,New England Journal ,Investigator Initiated Study ,Edoxaban Treatment ,Atrial Fibrillation ,Heart Rhythm Association Practical Guide ,Oral Anticoagulants ,Atrial Fibrillation Patients ,Outcomes Parameters ,Randomized Controlled Clinical ,Communication Lead ,

comparemela.com © 2020. All Rights Reserved.